
Join to View Full Profile
9725 Datapoint DrSte 106San Antonio, TX 78229
Phone+1 210-615-9358
Fax+1 210-455-1596
Dr. Hirabayashi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Current chief resident at University of Missouri and next Refractive Surgery fellow at Parkhurst NuVision.
Education & Training
- University of Missouri-ColumbiaResidency, Ophthalmology, 2020 - 2024
- University of Missouri-Columbia School of MedicineClass of 2020
- Saint Louis UniversityBS, Biology, Summa Cum Laude with Honors, 2012 - 2016
Certifications & Licensure
- TX State Medical License 2024 - 2027
- MO State Medical License 2020 - 2024
Awards, Honors, & Recognition
- Best of Poster Session ASCRS, 2024
- Chairman’s Award for Outstanding OKAP Score University of Missouri, 2023
- Chairman's Award for Outstanding OKAP Score University of Missouri Columbia School of Medicine, 2022
- Join now to see all
Publications & Presentations
PubMed
- A Retrospective Chart Review: The Presence of Anterior Hyaloid Separation Sign in Posterior Vitreous Detachment.Peeradol Wattanasirakul, Matthew T Hirabayashi, Raiyan Yousuf, Ahmed Elkeeb
Cureus. 2025-02-01 - 1 citationsVAULT: vault accuracy using deep learning technology: new image-based artificial intelligence model for predicting implantable collamer lens postoperative vault.Taj Nasser, Matthew Hirabayashi, Gurpal Virdi, Andrew Abramson, Gregory Parkhurst
Journal of Cataract and Refractive Surgery. 2024-05-01 - 3 citationsEffect of Selective Laser Trabeculoplasty on the Fellow Eye.Matthew Hirabayashi, Elizabeth Mellencamp, Sabrina Duong, Jayce Simoncic, Carlton Homan
Journal of Current Glaucoma Practice. 2024-01-25
Journal Articles
- Predictive Factors of Outcomes in Kahook Dual Blade Excisional Goniotomy Combined with PhacoemulsificationEli L Pratte, Junsang Cho, James R Landreneau, Matthew T Hirabayashi, Jella A An, Journal of Current Glaucoma Practice, 2022
- Comparison of 12-Month Outcomes of Kahook Dual Blade Excisional Goniotomy Performed by Attending versus Resident SurgeonsEli L. Pratte , James R. Landreneau , Matthew T. Hirabayashi , Jella A. An , Journal of Academic Ophthalmology, 12/2/2020
- Biostatistics 101: Perspective on Statistics in OphthalmologyMatthew Hirabayashi, Dale Smith, Jella An, JOJ Ophthalmology, 7/2/2019
Abstracts/Posters
- Predictive Factors for Outcomes of Selective Laser TrabeculoplastyMatthew Hirabayashi, Vikram Ponnusamy, Jella An M, American Glaucoma Society 2019 Meeting, San Francisco, California, 4/16/2019
- Outcome of Phacoemulsification with Kahook Dual Blade Goniotomy in Severe Glaucoma at 6 monthsMatthew Hirabayashi, Joshua King, Dayeong Lee, Jella An MD, 8th World Glaucoma Conference, Melbourne, Australia, 4/29/2019
- Comparison of ab-interno 360-degree Trabeculotomy and ab-interno Trabeculectomy using Dual BladeMatthew Hirabayashi, Joshua King, Dayeong Lee, Samuel Thomsen MD, Jella An MD, 8th World Glaucoma Conference, Melbourne, Australia, 4/29/2019
- Join now to see all
Authored Content
- Seeing is BelievingJanuary 2023
- Technological Innovation in OphthalmologyDecember 2022
- The Art of Focusing Light: Refractive Surgery FellowshipsDecember 2022
- Laser Trabeculoplasty in the Treatment of Open-angle GlaucomaDecember 2021
- The Curious Case of Cysts and SightJanuary 2019
- Principles of Biology I & II Supplementary ManualAugust 2014
- Join now to see all
Press Mentions
- Filling the App in KnowledgeJanuary 16th, 2023
- Virtual Resources for Aspiring OphthalmologistsJuly 15th, 2022
- New App Allows Surgeons to Search for FDA Approved IOLsJuly 15th, 2022
- Join now to see all
Professional Memberships
- Member
- Refractive Surgery Alliance SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: